I will guess that the result will be small if any benefit, and that will be the end of prurisol for psorioasis. It would be great if this were not the case
P2a too small to predict anything, really, despite what the company has said so far
New Information: Greatest Efficacy Seen in Patients with Moderate Psoriasis
Among patients participating in the study with the severest form of psoriasis, those having a baseline IGA score of 3 (“moderate”), the primary endpoint was met in 46.2% of patients who received Prurisol 200mg. This data was derived from analyses of all patients randomized across all 9 participating study sites.